InvestorsHub Logo
Followers 7
Posts 299
Boards Moderated 0
Alias Born 01/07/2010

Re: None

Thursday, 08/24/2017 3:08:23 PM

Thursday, August 24, 2017 3:08:23 PM

Post# of 461946
While we head into the Rett trial picturing A2-73 as a cure-all knowing nothing about trial design & outcome, please read these sobering words from the Rett Syndrome website: (https://www.rettsyndrome.org/make-a-difference/summer-appeal)

"Rett syndrome is an incredibly complex brain disorder and multiple approaches will be needed in order to treat or cure all of those impacted. No two individuals with Rett syndrome are the same, even if they share the same MECP2 mutation; so it is unlikely there will be one treatment approach. In addition to the complexity of the brain disorder, we have to think about the age of those affected at the time treatment options become available."

Would also like to point out/ask for an explanation from the board on the timelines in the following graphic - P1/2 + P3 = 3-10 years

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News